Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Dornstauder, Eugen
8  Ergebnisse:
Personensuche X
?
1

Healthcare resource utilization and costs of cardiovascular..:

Sidelnikov, Eduard ; Dornstauder, Eugen ; Jacob, Christian...
Journal of Medical Economics.  25 (2022)  1 - p. 1199-1206 , 2022
Link: https://doi.org/10.1080/..
 
?
2

Association of Treatment Intensity and Adherence to Lipid-L..:

Ahrens, Ingo ; Khachatryan, Artak ; Monga, Bondo..
Advances in Therapy.  38 (2021)  5 - p. 2532-2541 , 2021
Link: https://doi.org/10.1007/..
 
?
3

Fractures in untreated patients with osteoporosis in German..:

Böcker, Wolfgang ; Doobaree, Indraraj Umesh ; Khachatryan, Artak...
Osteoporosis International.  33 (2021)  1 - p. 77-86 , 2021
Link: https://doi.org/10.1007/..
 
?
4

Non-statin lipid-lowering therapy over time in very-high-ri..:

Katzmann, Julius L. ; Sorio-Vilela, Francesc ; Dornstauder, Eugen...
Clinical Research in Cardiology.  111 (2020)  3 - p. 243-252 , 2020
Link: https://doi.org/10.1007/..
 
?
5

Association of Treatment Intensity and Adherence to Lipid-L..:

Ahrens, Ingo ; Khachatryan, Artak ; Monga, Bondo..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107155/.  , 2021
Link: http://www.ncbi.nlm.nih...
 
?
6

Non-statin lipid-lowering therapy over time in very-high-ri..:

Katzmann, Julius L ; Sorio-Vilela, Francesc ; Dornstauder, Eugen...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8873069/.  , 2020
Link: http://www.ncbi.nlm.nih...
 
?
7

Non-statin lipid-lowering therapy over time in very-high-ri..:

Katzmann, Julius L ; Sorio-Vilela, Francesc ; Dornstauder, Eugen...
https://repository.publisso.de/resource/frl:6469948.  , 2020
Link: https://repository.publi..
 
?
8

Association of Treatment Intensity and Adherence to Lipid-L..:

figshare admin adisjournals (4767573) ; Ingo Ahrens (209808) ; Artak Khachatryan (10168891)...
https://figshare.com/articles/media/Association_of_Treatment_Intensity_and_Adherence_to_Lipid-Lowering_Therapy_With_Major_Adverse_Cardiovascular_Events_Among_Post-MI_Patients_in_Germany/14061737.  , 2021
Link: https://doi.org/10.6084/..
 
1-8